Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC (TOP0801)
This study is currently recruiting participants.
Verified April 2011 by Duke University
Sponsor:
Duke University
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00787267
First received: November 6, 2008
Last updated: December 11, 2012
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |